Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma.
Ye YH, Xin HY, Li JL, Li N, Pan SY, Chen L, Pan JY, Hu ZQ, Wang PC, Luo CB, Sun RQ, Fan J, Zhou J, Zhou ZJ, Zhou SL.
Ye YH, et al. Among authors: hu zq.
Clin Mol Hepatol. 2024 Oct;30(4):914-928. doi: 10.3350/cmh.2024.0296. Epub 2024 Aug 6.
Clin Mol Hepatol. 2024.
PMID: 39103994
Free PMC article.